Globus Medical (GMED) Cash & Current Investments (2011 - 2026)

Globus Medical (GMED) has reported Cash & Current Investments for 16 consecutive years, with $595.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cash & Current Investments rose 159.38% year-over-year to $595.1 million; the trailing twelve-month figure through Jun 2026 stood at $595.1 million (up 159.38% YoY), and the FY2025 full-year result was $557.2 million, down 37.39% from the prior year.
• Cash & Current Investments retreated to $595.1 million in Q2 2026 per GMED's latest filing, from $629.9 million in the prior quarter.
• Across five years, Cash & Current Investments topped out at $890.1 million in Q4 2024 and bottomed at $229.4 million in Q2 2025.
• Historically, Cash & Current Investments has averaged $511.8 million across 5 years, with a median of $483.1 million in 2022.
• The sharpest annual moves came in 2025 and 2026: Cash & Current Investments sank 53.45% in 2025, then jumped 159.38% in 2026.
• Over 5 years, Cash & Current Investments stood at $446.1 million in 2022, then advanced by 16.08% to $517.8 million in 2023, then soared by 71.9% to $890.1 million in 2024, then plunged by 37.39% to $557.2 million in 2025, then gained by 6.8% to $595.1 million in 2026.
• According to Business Quant data, Cash & Current Investments over the past three periods registered $595.1 million, $629.9 million, and $557.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.